Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
暂无分享,去创建一个
T. Kuroki | S. Shiomi | N. Sasaki | H. Jomura | H. Ochi | K. Koyama | J. Kawabe | D. Kawashima | T. Fukuda
[1] Y Yonekura,et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] Y. Yonekura,et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] S. Hirohashi,et al. Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical features and computed tomographic findings , 1993, Hepatology.
[4] R. Allen,et al. Combined liver cell and bile duct carcinoma. , 1949, The American journal of pathology.